These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 17161816

  • 1. Immunotherapy with CpG DNA conjugated with T-cell epitope peptide of an allergenic Cry j 2 protein is useful for control of allergic conditions in mice.
    Suzuki M, Ohta N, Min WP, Matsumoto T, Min R, Zhang X, Toida K, Murakami S.
    Int Immunopharmacol; 2007 Jan; 7(1):46-54. PubMed ID: 17161816
    [Abstract] [Full Text] [Related]

  • 2. Anti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in mice.
    Ishii M, Koyama A, Iseki H, Narumi H, Yokoyama N, Kojima N.
    Int Immunopharmacol; 2010 Sep; 10(9):1041-6. PubMed ID: 20584630
    [Abstract] [Full Text] [Related]

  • 3. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis.
    Sone T, Morikubo K, Miyahara M, Komiyama N, Shimizu K, Tsunoo H, Kino K.
    J Immunol; 1998 Jul 01; 161(1):448-57. PubMed ID: 9647255
    [Abstract] [Full Text] [Related]

  • 4. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine.
    Hiroi T, Takaiwa F.
    Curr Opin Allergy Clin Immunol; 2006 Dec 01; 6(6):455-60. PubMed ID: 17088651
    [Abstract] [Full Text] [Related]

  • 5. Analysis of helper T cell responses to Cry j 1-derived peptides in patients with nasal allergy: candidate for peptide-based immunotherapy of Japanese cedar pollinosis.
    Masuyama K, Chikamatsu K, Ikagawa S, Matsuoka T, Takahashi G, Yamamoto T, Endo S.
    Allergol Int; 2009 Mar 01; 58(1):63-70. PubMed ID: 19050376
    [Abstract] [Full Text] [Related]

  • 6. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens.
    Hirahara K, Tatsuta T, Takatori T, Ohtsuki M, Kirinaka H, Kawaguchi J, Serizawa N, Taniguchi Y, Saito S, Sakaguchi M, Inouye S, Shiraishi A.
    J Allergy Clin Immunol; 2001 Jul 01; 108(1):94-100. PubMed ID: 11447388
    [Abstract] [Full Text] [Related]

  • 7. DNA vaccine using invariant chain gene for delivery of CD4+ T cell epitope peptide derived from Japanese cedar pollen allergen inhibits allergen-specific IgE response.
    Toda M, Kasai M, Hosokawa H, Nakano N, Taniguchi Y, Inouye S, Kaminogawa S, Takemori T, Sakaguchi M.
    Eur J Immunol; 2002 Jun 01; 32(6):1631-9. PubMed ID: 12115646
    [Abstract] [Full Text] [Related]

  • 8. Intranasal CpG DNA therapy during allergen exposure in allergic rhinitis.
    Suzuki M, Matsumoto T, Ohta N, Min WP, Murakami S.
    Otolaryngol Head Neck Surg; 2007 Feb 01; 136(2):246-51. PubMed ID: 17275548
    [Abstract] [Full Text] [Related]

  • 9. PS80 interferes with the antiallergic effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, at very low concentration through modulation of Th1/Th2 balance.
    Kozutsumi D, Tsunematsu M, Yamaji T, Murakami R, Yokoyama M, Kino K.
    Immunology; 2006 Jul 01; 118(3):392-401. PubMed ID: 16827900
    [Abstract] [Full Text] [Related]

  • 10. Absence of nasal blockage in a Japanese cedar pollen-induced allergic rhinitis model mouse.
    Ogita-Nakanishi H, Nabe T, Mizutani N, Fujii M, Kohno S.
    Allergol Int; 2009 Jun 01; 58(2):171-8. PubMed ID: 19240378
    [Abstract] [Full Text] [Related]

  • 11. Establishment of an allergic rhinitis model in mice for the evaluation of nasal symptoms.
    Tsunematsu M, Yamaji T, Kozutsumi D, Murakami R, Kimura S, Kino K.
    Life Sci; 2007 Mar 20; 80(15):1388-94. PubMed ID: 17300813
    [Abstract] [Full Text] [Related]

  • 12. Oral administration of a T cell epitope inhibits symptoms and reactions of allergic rhinitis in Japanese cedar pollen allergen-sensitized mice.
    Murasugi T, Nakagami Y, Yoshitomi T, Hirahara K, Yamashita M, Taniguchi Y, Sakaguchi M, Ito K.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):143-8. PubMed ID: 15740735
    [Abstract] [Full Text] [Related]

  • 13. Induction of Th1 immune responses to Japanese cedar pollen allergen (Cry j 1) in mice immunized with Cry j 1 conjugated with CpG oligodeoxynucleotide.
    Kaburaki Y, Fujimura T, Kurata K, Masuda K, Toda M, Yasueda H, Chida K, Kawarai S, Sakaguchi M.
    Comp Immunol Microbiol Infect Dis; 2011 Mar 07; 34(2):157-61. PubMed ID: 20638725
    [Abstract] [Full Text] [Related]

  • 14. Roles of major oligosaccharides on Cry j 1 in human immunoglobulin E and T cell responses.
    Okano M, Kimura Y, Kino K, Michigami Y, Sakamoto S, Sugata Y, Maeda M, Matsuda F, Kimura M, Ogawa T, Nishizaki K.
    Clin Exp Allergy; 2004 May 07; 34(5):770-8. PubMed ID: 15144470
    [Abstract] [Full Text] [Related]

  • 15. Intraoral administration of a T-cell epitope peptide induces immunological tolerance in Cry j 2-sensitized mice.
    Yoshitomi T, Nakagami Y, Hirahara K, Taniguchi Y, Sakaguchi M, Yamashita M.
    J Pept Sci; 2007 Aug 07; 13(8):499-503. PubMed ID: 17600865
    [Abstract] [Full Text] [Related]

  • 16. Oral administration of a dominant T-cell determinant peptide inhibits allergen-specific TH1 and TH2 cell responses in Cry j 2-primed mice.
    Hirahara K, Saito S, Serizawa N, Sasaki R, Sakaguchi M, Inouye S, Taniguchi Y, Kaminogawa S, Shiraishi A.
    J Allergy Clin Immunol; 1998 Dec 07; 102(6 Pt 1):961-7. PubMed ID: 9847437
    [Abstract] [Full Text] [Related]

  • 17. Effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, on an experimental allergic rhinitis model in B10.S mice.
    Tsunematsu M, Yamaji T, Kozutsumi D, Murakami R, Kimura S, Kino K.
    Allergol Int; 2007 Dec 07; 56(4):465-72. PubMed ID: 17965586
    [Abstract] [Full Text] [Related]

  • 18. Immunotherapy of Chenopodium album induced asthma by intranasal administration of CpG oligodeoxynucleotides in BALB/c mice.
    Mousavi T, Salek Moghadam A, Falak R.
    Iran J Immunol; 2008 Mar 07; 5(1):57-63. PubMed ID: 18319526
    [Abstract] [Full Text] [Related]

  • 19. Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.
    Sone T, Dairiki K, Morikubo K, Shimizu K, Tsunoo H, Mori T, Kino K.
    Allergol Int; 2009 Jun 07; 58(2):237-45. PubMed ID: 19307778
    [Abstract] [Full Text] [Related]

  • 20. Oral immunotherapy against a pollen allergy using a seed-based peptide vaccine.
    Takagi H, Saito S, Yang L, Nagasaka S, Nishizawa N, Takaiwa F.
    Plant Biotechnol J; 2005 Sep 07; 3(5):521-33. PubMed ID: 17173638
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.